Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Global Markets Direct
April 30, 2014
36 Pages - GMD12079
$1,500.00

Summary

Global Markets Direct’s, ‘Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Achillion Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Achillion Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Achillion Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Achillion Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Achillion Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

- Evaluate Achillion Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Achillion Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Achillion Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Achillion Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Achillion Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Achillion Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Achillion Pharmaceuticals, Inc. Snapshot 5
Achillion Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Achillion Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Achillion Pharmaceuticals, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Achillion Pharmaceuticals, Inc. - Pipeline Products Glance 10
Achillion Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Achillion Pharmaceuticals, Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Achillion Pharmaceuticals, Inc. - Drug Profiles 14
ACH-3102 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
deldeprevir 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ACH-3080 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ACH-3107 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ACH-3422 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecule to Inhibit Topoisomerase for Bacterial Infections 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Small Molecules to Inhibit DNA Gyrase for Bacterial Infections 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Achillion Pharmaceuticals, Inc. - Pipeline Analysis 21
Achillion Pharmaceuticals, Inc. - Pipeline Products by Target 21
Achillion Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 22
Achillion Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 23
Achillion Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 24
Achillion Pharmaceuticals, Inc. - Recent Pipeline Updates 25
Achillion Pharmaceuticals, Inc. - Dormant Projects 30
Achillion Pharmaceuticals, Inc. - Discontinued Pipeline Products 31
Discontinued Pipeline Product Profiles 31
ACH-2928 31
Achillion Pharmaceuticals, Inc. - Company Statement 32
Achillion Pharmaceuticals, Inc. - Locations And Subsidiaries 34
Head Office 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

List of Tables
Achillion Pharmaceuticals, Inc., Key Information 5
Achillion Pharmaceuticals, Inc., Key Facts 5
Achillion Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7
Achillion Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8
Achillion Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9
Achillion Pharmaceuticals, Inc. - Phase II, 2014 10
Achillion Pharmaceuticals, Inc. - Phase I, 2014 11
Achillion Pharmaceuticals, Inc. - Preclinical, 2014 12
Achillion Pharmaceuticals, Inc. - Discovery, 2014 13
Achillion Pharmaceuticals, Inc. - Pipeline by Target, 2014 21
Achillion Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 22
Achillion Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 23
Achillion Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 24
Achillion Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 25
Achillion Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 30
Achillion Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 31

List of Figures
Achillion Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2014 7
Achillion Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8
Achillion Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9
Achillion Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2014 21
Achillion Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2014 22
Achillion Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2014 23
Achillion Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 24

$1,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax